MOTS-c: a promising mitochondrial-derived peptide for therapeutic exploitation
Biomedicine and Pharmacotherapy
2023
Study summary
Narrative review on MOTS-c and its translational potential in metabolic disease and aging.
Peptides studied
Goals studied
Stack studied
Metabolic Stack
Key findings
The review emphasized preclinical promise and lack of established clinical application methods.
Study details
Study type
review article
Journal
Biomedicine and Pharmacotherapy
DOI / PubMed
10.1016/j.biopha.2023.114138
Year
2023
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.